Neuroprotective effects of cuscutae semen in a mouse model of parkinson's disease

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Ye, Minsook ^a   Lee, Seul Gi ^a   Chung, Eun Sook ^a   Lim, Su Jin ^a   Kim, Won Seob ^a   Yoon, Heera ^a   Kim, Sun Kwang ^a   Ahn, Kwang Sung ^a   Jang, Young Pyo ^a   Bae, Hyunsu ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CUSCUTA EXTRACT; GLUTATHIONE PEROXIDASE; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL COUNTING; CELL DEATH; CELL DIFFERENTIATION; CELL LOSS; CELL SURVIVAL; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CUSCUTA; CUSCUTAE SEMEN; DRUG EFFECT; ENZYME ACTIVATION; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICROGLIA; MOTOR ACTIVITY; MOTOR COORDINATION; MOUSE; MOUSE MODEL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; POLE TEST; PRIORITY JOURNAL; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS;

EID: 84934964391     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/150153     Document Type: Article

References (45)

1. J. H. Liu, S. Ho, T. Lai, T. Liu, P. Chi, and R. Wu, "Protective efects of Chinese herbs on D-galactose-induced oxidative damage," Methods and Findings in Experimental and Clinical Pharmacology, vol. 25, no. 6, pp. 447-452, 2003.
2. X. M. Wang, H. Fu, and G. X. Liu, "Efect of wuzi yanzong pill and its disassembled prescription on mitochondrial DNA deletion, respiratory chain complexes and ATP synthesis in aged rats," Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 21, no. 6, pp. 437-440, 2001.
3. N. Ogawa, "Dopamine neurotransmission and treatments for Parkinson's disease in the molecular biology era," European Neurology, vol. 38, supplement 1, pp. 2-5, 1997.
4. S. Przedborski, V. Jackson-Lewis, A. B. Naini et al., "The parkinsonian toxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyri-dine (MPTP): a technical review of its utility and safety," Journal of Neurochemistry, vol. 76, no. 5, pp. 1265-1274, 2001.
5. Y. C. Chung, S. R. Kim, J. Park et al., "Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation," Neuropharmacology, vol. 60, no. 6, pp. 963-974, 2011.
6. E. C. Hirsch, T. Breidert, E. Rousselet, S. Hunot, A. Hartmann, and P. P. Michel, "The role of glial reaction and infammation in Parkinson's disease," Annals of the New York Academy of Sciences, vol. 991, pp. 214-228, 2003.
7. P. L. McGeer and E. G. McGeer, "Glial reactions in Parkinson's disease," Movement Disorders, vol. 23, no. 4, pp. 474-483, 2008.
8. M. L. Block, L. Zecca, and J.-S. Hong, "Microglia-mediated neurotoxicity: uncovering the molecular mechanisms," Nature Reviews Neuroscience, vol. 8, no. 1, pp. 57-69, 2007.
9. H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger, "Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neuro-chemical correlations," Journal of the Neurological Sciences, vol. 20, no. 4, pp. 415-455, 1973.
10. P. Riederer and S. Wuketich, "Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of infu-ential factors in human brain amine analysis," Journal of Neural Transmission-General Section, vol. 38, no. 3-4, pp. 277-301, 1976.
11. A. E. Lang and A. M. Lozano, "Parkinson's disease. First of two parts," The New England Journal of Medicine, vol. 339, no. 15, pp. 1044-1053, 1998.
12. E. Koutsilieri, C. Scheller, F. Tribl, and P. Riederer, "Degeneration of neuronal cells due to oxidative stress-microglial contribution," Parkinsonism and Related Disorders, vol. 8, no. 6, pp. 401-406, 2002.
13. G. T. Liberatore, V. Jackson-Lewis, S. Vukosavic et al., "Inducible nitric oxide synthase stimulates dopaminergic neurodegenera-tion in the MPTP model of Parkinson disease," Nature Medicine, vol. 5, no. 12, pp. 1403-1409, 1999.
14. D.-K. Choi, S. Pennathur, C. Perier et al., "Ablation of the infammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice," The Journal of Neuroscience, vol. 25, no. 28, pp. 6594-6600, 2005.
15. D. Wu, P. Teismann, K. Tieu et al., "NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 10, pp. 6145-6150, 2003.
16. H. Gao, B. Liu, W. Zhang, and J. Hong, "Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease," The FASEB Journal, vol. 17, no. 13, pp. 1954-1956, 2003.
17. L. Yang, Q. Chen, F. Wang, and G. Zhang, "Antiosteoporotic compounds from seeds of Cuscuta chinensis," Journal of Ethnopharmacology, vol. 135, no. 2, pp. 553-560, 2011.
18. F. L. Yen, T. Wu, L. Lin, T. Cham, and C. Lin, "Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats," Food and Chemical Toxicology, vol. 46, no. 5, pp. 1771-1777, 2008.
19. D. Qin, B. She, Y. She, and J. Wang, "Efects of favonoids from Semen Cuscutae on the reproductive system in male rats," Asian Journal of Andrology, vol. 2, no. 2, pp. 99-102, 2000.
20. H. M. Yang, H. Shin, Y. Kang, and J. Kim, "Cuscuta chinensis extract promotes osteoblast diferentiation and mineralization in human osteoblast-like MG-63 cells," Journal of Medicinal Food, vol. 12, no. 1, pp. 85-92, 2009.
21. X. Bao, Z. Wang, J. Fang, and X. Li, "Structural features of an immunostimulating and antioxidant acidic polysaccharide from the seeds of Cuscuta chinensis," Planta Medica, vol. 68, no. 3, pp. 237-243, 2002.
22. Z. Wang, J.-N. Fang, D.-L. Ge, and X.-Y. Li, "Chemical characterization and immunological activities of an acidic polysac-charide isolated from the seeds of Cuscuta chinensis Lam," Acta Pharmacologica Sinica, vol. 21, no. 12, pp. 1136-1140, 2000.
23. E. S. Chung, Y. C. Chung, E. Bok et al., "Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress," Brain Research, vol. 1363, pp. 143-150, 2010.
24. G. D. Zeevalk, L. P. Bernard, D. S. Albers, O. Mirochnitchenko, W. J. Nicklas, and P. K. Sonsalla, "Energy stress-induced dopamine loss in glutathione peroxidase-overexpressing trans-genic mice and in glutathione-depleted mesencephalic cultures," Journal of Neurochemistry, vol. 68, no. 1, pp. 426-429, 1997.
25. C. F. Pereira and C. R. D. Oliveira, "Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis," Neuroscience Research, vol. 37, no. 3, pp. 227-236, 2000.
26. M. Ye, Y. Li, Y. Yan, H. Liu, and X. Ji, "Determination of favonoids in Semen Cuscutae by RP-HPLC," Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 3-4, pp. 621-628, 2002.
27. L. Wu, X. Yang, Z. Huang, H. Liu, and G. Wu, "In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik," Acta Pharmacologica Sinica, vol. 28, no. 3, pp. 404-409, 2007.
28. J. Wang, M. Wang, Y. Ou, and Q. Wu, "Efects of favonoids from semen Cuscutae on changes of beta-EP in hypothalamuses and FSH and LH in anterior pituitaries in female rats exposed to psychologic stress," Journal of Chinese medicinal materials, vol. 25, no. 12, pp. 886-888, 2002.
29. J. Ke and R. Duan, "Efects of favonoids from semen cuscutae on the hippocampal-hypothalamic-pituitary-ovarian sex hormone receptors in female rats exposed to psychological stress," Clinical and Experimental Obstetrics and Gynecology, vol. 40, no. 2, pp. 271-274, 2013.
30. A. D. Kraf and G. J. Harry, "Features of microglia and neuroinfammation relevant to environmental exposure and neurotoxicity," International Journal of Environmental Research and Public Health, vol. 8, no. 7, pp. 2980-3018, 2011.
31. M. L. Block and J. S. Hong, "Microglia and infammation-mediated neurodegeneration: multiple triggers with a common mechanism," Progress in Neurobiology, vol. 76, no. 2, pp. 77-98, 2005.
32. R. M. Ransohof and V. H. Perry, "Microglial physiology: unique stimuli, specialized responses," Annual Review of Immunology, vol. 27, pp. 119-145, 2009.
33. L.-Y. Zang and H. P. Misra, "Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyri-dine," Journal of Biological Chemistry, vol. 268, no. 22, pp. 16504-16512, 1993.
34. D. Muralikrishnan and K. P. Mohanakumar, "Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity in mice," The FASEB Journal, vol. 12, no. 10, pp. 905-912, 1998.
35. A. Oyagi, Y. Oida, H. Hara et al., "Protective efects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease," Brain Research, vol. 1214, pp. 169-176, 2008.
36. J. Zhang, G. Perry, M. A. Smith et al., "Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons," The American Journal of Pathology, vol. 154, no. 5, pp. 1423-1429, 1999.
37. S. Kasture, M. Mohan, and V. Kasture, "Mucuna pruriens seeds in treatment of Parkinson's disease: pharmacological review," Oriental Pharmacy and Experimental Medicine, vol. 13, no. 3, pp. 165-174, 2013.
38. M. F. Beal, "Oxidatively modifed proteins in aging and disease," Free Radical Biology and Medicine, vol. 32, no. 9, pp. 797-803, 2002.
39. S. Fahn and G. Cohen, "The oxidant stress hypothesis in Parkinson's disease: evidence supporting it," Annals of Neurology, vol. 32, no. 6, pp. 804-812, 1992.
40. R. L. Miller, M. James-Kracke, G. Y. Sun, and A. Y. Sun, "Oxidative and infammatory pathways in parkinson's disease," Neurochemical Research, vol. 34, no. 1, pp. 55-65, 2009.
41. T. Kadota, T. Yamaai, Y. Saito et al., "Expression of dopamine transporter at the tips of growing neurites of PC12 cells," Journal of Histochemistry and Cytochemistry, vol. 44, no. 9, pp. 989-996, 1996.
42. W. Dauer and S. Przedborski, "Parkinson's disease: mechanisms and models," Neuron, vol. 39, no. 6, pp. 889-909, 2003.
43. Z. T. Zhang, X. Cao, N. Xiong et al., "Morin exerts neuroprotec-tive actions in Parkinson disease models in vitro and in vivo," Acta Pharmacologica Sinica, vol. 31, no. 8, pp. 900-906, 2010.
44. V. Vitvitsky, M. Tomas, A. Ghorpade, H. E. Gendelman, and R. Banerjee, "A functional transsulfuration pathway in the brain links to glutathione homeostasis," The Journal of Biological Chemistry, vol. 281, no. 47, pp. 35785-35793, 2006.
45. M. Lin, Y. Yu, K. Chen et al., "Kaempferol from Semen cuscutae attenuates the immune function of dendritic cells," Immunobiology, vol. 216, no. 10, pp. 1103-1109, 2011.